<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00575835</url>
  </required_header>
  <id_info>
    <org_study_id>77/2006</org_study_id>
    <nct_id>NCT00575835</nct_id>
  </id_info>
  <brief_title>Oral Vitamin D Supplementation in Elderly Women</brief_title>
  <official_title>Oral Vitamin D Supplementation in Elderly Women: Twice a Day or Three Times a Year? A Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Päivikki and Sakari Sohlberg Foundation, Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lilly Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Helsinki University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare oral vitamin D supplementation administered in two
      different ways, namely either twice a day (800IU/d, 292000IU/y) or three times a year
      (97333IU every 4 months, 292000IU/y) in elderly women in combination with daily
      supplementation of calcium 1 gram. We will 1)compare the blood concentrations of 25 OH
      vitamin D in the two treatment groups amd monitor if a sufficient and safe concentration of
      25OH D in blood can be maintained with these two treatments.2) Find out seasonal variation in
      vitamin D concentrations in these treatments. 3) Find out safety of these treatments
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">October 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood 25 OH D vitamin concentrations</measure>
    <time_frame>8 times during the year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>serum calcium, 24-hour calcium excretion in urine, creatinine clearance</measure>
    <time_frame>8 times during the year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Optimal Vitamin D Administration</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin D twice daily</intervention_name>
    <description>Kalsipos-D, vitamin D3 400 ID/tbl, 2 tbl/day for one year</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3 oil three times in a year</intervention_name>
    <description>Vigantol oil , D3 20000IU/ml, 4.9 ml every four months for one year</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Females

          -  70-80 years

          -  Living in the community

        Exclusion Criteria:

          -  Renal disease

          -  Diseases that contraindicate vitamin D supplementation

          -  Medications affecting bone

          -  Malignancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Helsinki University Central Hospital, department of medicine, division of endocrinology</name>
      <address>
        <city>Helsinki</city>
        <zip>00029 HUS</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>December 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2007</study_first_submitted>
  <study_first_submitted_qc>December 17, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2007</study_first_posted>
  <last_update_submitted>December 26, 2007</last_update_submitted>
  <last_update_submitted_qc>December 26, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 8, 2008</last_update_posted>
  <responsible_party>
    <name_title>Matti Välimäki, MD, Ph.D</name_title>
    <organization>Helsinki University Central Hospital, Department of Medicine, Division of Endocrinology</organization>
  </responsible_party>
  <keyword>vitamin D</keyword>
  <keyword>seasonal variation</keyword>
  <keyword>PTH</keyword>
  <keyword>bone markers</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

